Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition
Press Releases
RegCell today announced the closing of an oversubscribed seed round and its transition to a U.S.-based company.